Veterans trial aims to halt fatty liver disease with common hormone
NCT ID NCT05526144
Summary
This study is testing whether a low dose of thyroid hormone can treat a serious form of fatty liver disease called NASH in Veterans. Researchers believe the hormone may help the liver's energy centers burn excess fat more effectively. The trial will compare the hormone against a placebo in 128 participants over a year to see if it improves liver health and reduces scarring.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Harry S. Truman Memorial, Columbia, MO
RECRUITINGColumbia, Missouri, 65201-5275, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.